S.140 updates federal theft laws to specifically address organized retail crime by raising the monetary threshold for prosecution to $5,000 in stolen goods over 12 months and expanding definitions to include coordinated theft operations. It creates a new Homeland Security Coordination Center within 90 days to unify federal, state, local, and tribal law enforcement efforts with retailers. The center will share threat intelligence, track crime trends, and produce annual public reports on organized retail crime patterns. These changes directly affect retailers facing financial losses, law enforcement agencies, and criminal organizations profiting from theft.
The A PLUS Act (HR 631) allows states to consolidate federal education funds into a single funding stream, reducing administrative burdens for school districts. It requires states to submit a "declaration of intent" outlining which programs they’ll bundle (excluding special education funds), report annual student progress data to parents, and ensure federal funds supplement - rather than replace - state education spending. States must limit administrative costs to 1% of consolidated funds (3% if excluding Title I) and maintain public accountability through transparent reporting on achievement gaps and funding use. The act directly affects states, school districts, and students - particularly disadvantaged groups - by streamlining fund management while mandating public reporting on educational outcomes.
HRES 68 is a symbolic resolution supporting National Catholic Schools Week, which recognizes Catholic schools' educational and community contributions. It does not create new policies or funding but formally endorses the week's goals - highlighting Catholic schools' academic achievements, diverse student enrollment, and role in fostering moral development. The resolution was introduced by multiple House members and passed without opposition, focusing on acknowledgment rather than legislative action. It directly affects Catholic schools by affirming their nationwide impact, though it has no binding effect on federal programs or resources.
Commercial Fishing and Seafood Business Act of 2023 This bill expands a provision that exempts certain H-2B visas (temporary nonagricultural laborers) from the annual cap of 66,000 on such visas. Under this bill, the exemption shall apply to H-2B visas issued for employment (1) on a commercial fishing vessel or shrimp trawler; or (2) in the processing of fish, baitfish, or fishery products. Currently, this exemption only applies to H-2B visas issued for certain employment related to the processing of fish roe.
This bill amends the U.S. Code to expand appeal rights for certain postal employees. It allows non-unionized postal workers in supervisory, professional, technical, clerical, administrative, or managerial roles (covered under the Executive and Administrative Schedule) to directly appeal personnel decisions to the Merit Systems Protection Board (MSPB). Previously, these employees may have lacked this specific appeal path. The change clarifies their eligibility under Section 1005(a)(4)(A)(ii)(I) of Title 39, U.S. Code, ensuring they can seek MSPB review for employment-related disputes.
This bill requires the U.S. Postal Service to provide written proposals to supervisors' organizations 60 days before pay/benefit decisions expire or after new collective bargaining agreements are reached. It directly affects postal supervisors and managers covered by collective bargaining agreements regarding their pay policies, schedules, and fringe benefits. The key mechanism establishes clear timelines for negotiations and mandates that any dispute resolution panel must issue a binding final decision within 15 days of receiving input from both parties. This aims to streamline the process for resolving pay and benefits disputes between the Postal Service and supervisory staff organizations.
The HEAL Act (HR 603) requires the U.S. Holocaust Memorial Museum Director to study how public elementary and secondary schools teach about the Holocaust and related antisemitism. The study will examine curriculum requirements, teaching methods (like project-based learning), instructional materials, and assessment approaches across states and school districts. It specifically analyzes whether Holocaust education is mandatory, optional, or integrated across subjects, and how schools address antisemitism and genocide prevention. The resulting report, due within 180 days of the study or three years after enactment, will inform Congress but does not change current school policies. This is a data-gathering measure, not a policy mandate.
Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.
This bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.
Protecting Life and Taxpayers Act of 2023 This bill requires federally funded entities to certify that they will not, subject to certain exceptions, perform abortions or provide funding to other entities that perform abortions. The bill provides exceptions for abortions (1) in cases of rape or incest; or (2) when the life of the woman is in danger due to a physical disorder, injury, or illness.
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.
This bill prohibits federal funding to Planned Parenthood Federation of America and its affiliates for one year unless they certify they won't perform or fund abortions (with exceptions for rape/incest or life-threatening conditions). It redirects $235 million in existing funding to community health centers for women's health services like contraception, cancer screenings, and prenatal care. The bill explicitly states that redirected funds will continue to support all women's health services previously provided by Planned Parenthood. It also requires repayment of funds if Planned Parenthood violates the certification, and clarifies that overall federal funding for women's health services remains unchanged.
